Regulation of HAM function by proteolytic processing
Regulation of HAM function by proteolytic processing
批准号:
13680709
负责人:
MIYAZAWA Keiji
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
HGF激活因子抑制剂(HAI-1)是HGF激活因子(HGFA)的蛋白性抑制剂,其蛋白水解激活肝细胞生长因子(HGF)。HGF是一种参与损伤后组织再生和修复的多功能细胞因子。HAI-1是一种I型膜蛋白,通过蛋白水解作用分泌为40 kD或58 kD的HAI-1。40kD HAI-1含有1个Kunitz结构域(Kunitz 1),而58 kD HAI-1含有2个Kunitz结构域(Kunitz 1和Kunitz 2)。我们生成了每个Kunitz结构域的缺失突变体,发现Kunitz 1主要参与抑制HGFA。虽然58 kD hai -1含有两个Kunitz结构域,但其对HGFA的抑制活性很弱。我们发现两个Kunitz结构域相互掩盖,从而降低了整个蛋白的抑制活性。当三分之二的大鼠肝脏被切除时,残余肝脏中的促生长因子显著增加,但活性生长因子仅少量存在。然后,我们在部分肝切除术后24小时通过门静脉给予活性HGFA,并检查对肝脏再生的影响。给药HGFA导致残肝中原HGF的激活,并诱导c-Met (HGF受体)的酪氨酸磷酸化。此外,肝细胞标记指数升高,促进肝块的恢复。然而,我们需要大量的HGFA才能获得肝脏再生的显著增强,这表明HAI-1等组织源性抑制剂在体内调节HGFA活性方面起着重要作用。
英文摘要
HGF activator inhibitor (HAI-1) is a proteinaceous inhibitor of HGF activator (HGFA), which proteolytically activates hepatocyte growth factor (HGF). HGF is a multifunctional cytokine that is involved in regeneration and tissue repair after injury. HAI-1 is synthesized as a type I membrane protein, and secreted as a 40 kD HAI-1 or 58 kD HAI-1 by proteolytic processing. 40kD HAI-1 contains one Kunitz domain (Kunitz 1), whereas 58 kD HAI-1 contains two Kunitz domains (Kunitz 1 and 2). We generated deletion mutants of each Kunitz domains, and found that Kunitz 1is mainly involved in inhibition of HGFA. Although 58 kD HAI-1contains two Kunitz domains, its inhibitory activity for HGFA is very weak. We found that two Kunitz domains masked each other, thus lowering the inhibitory activity of the whole protein.When two-thirds of rat liver is resected, pro-HGF in the residual liver increases dramatically, but the active HGF is present in only a small amount. We then administered active HGFA via portal vein 24 h after partial hepatectomy, and examined the effect on liver regeneration. Administration of HGFA caused activation of pro-HGF in the residual liver and induced tyrosine phosphorylation of c-Met (HGF receptor). In addition, labeling index of hepatocytes was increased, and recovery of liver mass was promoted. We needed, however, a large amount of HGFA to obtain significant enhancement of liver regeneration, indicating that tissue-derived inhibitors such as HAI-1 play important roles in regulating activity of HGFA in vivo.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Itoh, H., et al.: "Identification of hepatocyte growth factor activator inhibitor type 2 (HAI-2)-related small peptide (H2RSP)"Biochem. Biophys. Res. Commum.. 288. 390-399 (2001)
Itoh, H., et al.:“肝细胞生长因子激活剂抑制剂 2 型 (HAI-2) 相关小肽 (H2RSP) 的鉴定”Biochem。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Denda, K. et al.: "Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1"J.Biol.Chem.. 277. 14053-14059 (2002)
Denda, K. 等人:“肝细胞生长因子激活剂抑制剂 1 型中 Kunitz 结构域的功能表征”J.Biol.Chem.. 277. 14053-14059 (2002)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kaibori, M. et al.: "Impairment of activation of hepatocyte growth factor precursor into its mature form in rats with liver cirrhosis"J.Surg.Res.. 106. 108-114 (2002)
Kaibori, M. 等人:“肝硬化大鼠中肝细胞生长因子前体激活至其成熟形式的损伤”J.Surg.Res.. 106. 108-114 (2002)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kataoka, H., Itoh, H., Shimomura, T., Nuki, Y., Naganuma, S., and Miyazawa, K.: "Regulation of hepatocyte growth factor (HGF) activation on cell surface : Insights into an emerging class of cell surface protease inhibitors"LifeXY. 1. 1036-1042 (2001)
Kataoka, H.、Itoh, H.、Shimomura, T.、Nuki, Y.、Naganuma, S. 和 Miyazawa, K.:“细胞表面肝细胞生长因子 (HGF) 激活的调节:对新兴类别的见解
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kaibori, M. et al.: "Exogenously administered HGF activator augments liver regeneration through the production of biologically active HGF"Biochem. Biophys. Res. Commun. 290. 475-481 (2002)
Kaibori, M. 等人:“外源性施用 HGF 激活剂通过产生生物活性 HGF 增强肝脏再生”Biochem。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 10 条
Development of a method to detect heterogeneity of Smad transcriptional complexes
-
批准号:17K19589
-
项目类别:Grant-in-Aid for Challenging Research (Exploratory)
-
资助金额:$4.16万
-
财政年份:2017
-
负责人:MIYAZAWA Keiji
-
依托单位:
Development of cell-response selective regulation of TGF-βsignaling
-
批准号:22390052
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.98万
-
财政年份:2010
-
负责人:MIYAZAWA Keiji
-
依托单位:
Molecular basis of the signaling networks that regulate vasculogenesis
-
批准号:17570106
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2005
-
负责人:MIYAZAWA Keiji
-
依托单位:
Molecular mechanism of vascular endothelial/mural cell differentiation by receptor tyrosine kinases
-
批准号:15570110
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.37万
-
财政年份:2003
-
负责人:MIYAZAWA Keiji
-
依托单位:
Use of hepatocyte growth factor activator for limited digestion of tagged fusion proteins
-
批准号:11557181
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$8.32万
-
财政年份:1999
-
负责人:MIYAZAWA Keiji
-
依托单位:
Mechanism of ligand : receptor complex assembly of platelet-derived growth factor (PDGF)
-
批准号:10680602
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.86万
-
财政年份:1998
-
负责人:MIYAZAWA Keiji
-
依托单位:
国内基金
海外基金
登录
查看更多内容
内源性蛋白酶抑制剂SerpinA3N对缺血性脑卒中后血脑屏障的保护作用及其表达调控机制
-
批准号:82371317
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:万杰清
-
依托单位:
新生儿坏死性小肠结肠炎中去泛素化酶USP15调控ILC3分化损伤肠道粘膜屏障的致病机制研究
-
批准号:82371711
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:吕志宝
-
依托单位:
抑素蛋白(prohibitin)1调控蛋白酶激活受体(protease-activated receptor)1内化转运及降解的功能和机制
-
批准号:31270835
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2012
-
负责人:张云
-
依托单位:
三角帆蚌丝氨酸蛋白酶(serine protease)基因的克隆、表达调控与功能研究
-
批准号:31040083
-
项目类别:专项基金项目
-
资助金额:10.0万元
-
批准年份:2010
-
负责人:肖调义
-
依托单位:
熊胆粉中具抗丙型肝炎病毒作用的大分子蛋白纯化鉴定及药理学特性研究
-
批准号:30973886
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2009
-
负责人:王喜军
-
依托单位:
铁螯合剂对蛋白酶体抑制剂所致神经元变性的拮抗作用
-
批准号:30670748
-
项目类别:面上项目
-
资助金额:8.0万元
-
批准年份:2006
-
负责人:张雄
-
依托单位: